vs

Side-by-side financial comparison of Phathom Pharmaceuticals, Inc. (PHAT) and Velocity Financial, Inc. (VEL). Click either name above to swap in a different company.

Phathom Pharmaceuticals, Inc. is the larger business by last-quarter revenue ($57.6M vs $51.6M, roughly 1.1× Velocity Financial, Inc.). On growth, Phathom Pharmaceuticals, Inc. posted the faster year-over-year revenue change (94.1% vs 32.8%). Velocity Financial, Inc. produced more free cash flow last quarter ($17.9M vs $-167.0M).

Phathom Pharmaceuticals is a clinical-stage biopharmaceutical firm focused on developing and commercializing innovative therapies for gastrointestinal diseases. Its lead product candidates address acid-related disorders, inflammatory bowel disease, and other GI conditions, serving patients mainly across North America and Europe.

Velocity Financial, Inc. is a U.S.-headquartered real estate finance company that offers specialized mortgage loan solutions primarily for residential investment properties. It partners with independent mortgage brokers nationwide, providing real estate investors with short-term bridge loans and long-term rental property financing options tailored to their operational needs.

PHAT vs VEL — Head-to-Head

Bigger by revenue
PHAT
PHAT
1.1× larger
PHAT
$57.6M
$51.6M
VEL
Growing faster (revenue YoY)
PHAT
PHAT
+61.3% gap
PHAT
94.1%
32.8%
VEL
More free cash flow
VEL
VEL
$184.9M more FCF
VEL
$17.9M
$-167.0M
PHAT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
PHAT
PHAT
VEL
VEL
Revenue
$57.6M
$51.6M
Net Profit
$34.8M
Gross Margin
86.7%
Operating Margin
97.0%
Net Margin
67.3%
Revenue YoY
94.1%
32.8%
Net Profit YoY
71.6%
67.0%
EPS (diluted)
$0.90

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PHAT
PHAT
VEL
VEL
Q4 25
$57.6M
$51.6M
Q3 25
$49.5M
$49.1M
Q2 25
$39.5M
$47.6M
Q1 25
$28.5M
$37.5M
Q4 24
$29.7M
$38.9M
Q3 24
$16.4M
$35.1M
Q2 24
$7.3M
$32.4M
Q1 24
$29.5M
Net Profit
PHAT
PHAT
VEL
VEL
Q4 25
$34.8M
Q3 25
$-30.0M
$25.4M
Q2 25
$-75.8M
$26.0M
Q1 25
$-94.3M
$18.9M
Q4 24
$20.8M
Q3 24
$-85.6M
$15.8M
Q2 24
$-91.4M
$14.8M
Q1 24
$17.3M
Gross Margin
PHAT
PHAT
VEL
VEL
Q4 25
86.7%
Q3 25
87.5%
Q2 25
87.2%
Q1 25
86.9%
Q4 24
87.1%
Q3 24
85.6%
Q2 24
81.2%
Q1 24
Operating Margin
PHAT
PHAT
VEL
VEL
Q4 25
97.0%
Q3 25
-30.8%
72.1%
Q2 25
-151.7%
71.3%
Q1 25
-276.5%
71.7%
Q4 24
82.5%
Q3 24
-433.0%
60.6%
Q2 24
-1055.4%
61.3%
Q1 24
78.8%
Net Margin
PHAT
PHAT
VEL
VEL
Q4 25
67.3%
Q3 25
-60.5%
51.7%
Q2 25
-191.9%
54.6%
Q1 25
-330.7%
50.4%
Q4 24
53.5%
Q3 24
-523.3%
45.1%
Q2 24
-1248.6%
45.6%
Q1 24
58.5%
EPS (diluted)
PHAT
PHAT
VEL
VEL
Q4 25
$0.90
Q3 25
$-0.41
$0.65
Q2 25
$-1.05
$0.69
Q1 25
$-1.31
$0.51
Q4 24
$0.56
Q3 24
$-1.32
$0.44
Q2 24
$-1.56
$0.42
Q1 24
$0.49

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PHAT
PHAT
VEL
VEL
Cash + ST InvestmentsLiquidity on hand
$130.0M
$92.1M
Total DebtLower is stronger
$209.1M
Stockholders' EquityBook value
$-438.2M
$672.5M
Total Assets
$259.1M
$7.4B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PHAT
PHAT
VEL
VEL
Q4 25
$130.0M
$92.1M
Q3 25
$135.2M
$99.0M
Q2 25
$149.6M
$79.6M
Q1 25
$212.3M
$51.7M
Q4 24
$297.3M
$49.9M
Q3 24
$334.7M
$44.1M
Q2 24
$276.2M
$47.4M
Q1 24
$34.8M
Total Debt
PHAT
PHAT
VEL
VEL
Q4 25
$209.1M
Q3 25
$207.1M
Q2 25
$205.1M
Q1 25
$203.2M
Q4 24
$201.4M
Q3 24
$175.7M
Q2 24
$174.4M
Q1 24
Stockholders' Equity
PHAT
PHAT
VEL
VEL
Q4 25
$-438.2M
$672.5M
Q3 25
$-422.5M
$634.3M
Q2 25
$-405.8M
$597.9M
Q1 25
$-338.4M
$563.2M
Q4 24
$-253.6M
$516.9M
Q3 24
$-187.1M
$484.6M
Q2 24
$-233.8M
$471.3M
Q1 24
$452.9M
Total Assets
PHAT
PHAT
VEL
VEL
Q4 25
$259.1M
$7.4B
Q3 25
$240.3M
$7.0B
Q2 25
$250.2M
$6.5B
Q1 25
$294.2M
$6.0B
Q4 24
$378.3M
$5.5B
Q3 24
$387.0M
$5.2B
Q2 24
$319.4M
$4.9B
Q1 24
$4.6B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PHAT
PHAT
VEL
VEL
Operating Cash FlowLast quarter
$-166.8M
$18.2M
Free Cash FlowOCF − Capex
$-167.0M
$17.9M
FCF MarginFCF / Revenue
-290.0%
34.6%
Capex IntensityCapex / Revenue
0.4%
0.5%
Cash ConversionOCF / Net Profit
0.52×
TTM Free Cash FlowTrailing 4 quarters
$-328.9M
$40.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PHAT
PHAT
VEL
VEL
Q4 25
$-166.8M
$18.2M
Q3 25
$-14.1M
$11.5M
Q2 25
$-62.7M
$7.7M
Q1 25
$-84.9M
$3.5M
Q4 24
$-266.8M
$37.8M
Q3 24
$-63.6M
$-17.6M
Q2 24
$-70.7M
$11.5M
Q1 24
$10.6M
Free Cash Flow
PHAT
PHAT
VEL
VEL
Q4 25
$-167.0M
$17.9M
Q3 25
$-14.1M
$11.4M
Q2 25
$-62.8M
$7.6M
Q1 25
$-84.9M
$3.5M
Q4 24
$-266.9M
$37.5M
Q3 24
$-63.6M
$-17.6M
Q2 24
$-70.8M
$11.4M
Q1 24
$10.5M
FCF Margin
PHAT
PHAT
VEL
VEL
Q4 25
-290.0%
34.6%
Q3 25
-28.6%
23.2%
Q2 25
-159.0%
15.9%
Q1 25
-297.9%
9.2%
Q4 24
-899.8%
96.4%
Q3 24
-389.0%
-50.3%
Q2 24
-966.2%
35.1%
Q1 24
35.8%
Capex Intensity
PHAT
PHAT
VEL
VEL
Q4 25
0.4%
0.5%
Q3 25
0.1%
0.1%
Q2 25
0.2%
0.2%
Q1 25
0.1%
0.2%
Q4 24
0.5%
0.7%
Q3 24
0.3%
0.2%
Q2 24
0.6%
0.3%
Q1 24
0.1%
Cash Conversion
PHAT
PHAT
VEL
VEL
Q4 25
0.52×
Q3 25
0.45×
Q2 25
0.29×
Q1 25
0.19×
Q4 24
1.81×
Q3 24
-1.11×
Q2 24
0.78×
Q1 24
0.61×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PHAT
PHAT

Segment breakdown not available.

VEL
VEL

Related Party$19.3M37%
Nonrelated Party$16.9M33%
Other$15.4M30%

Related Comparisons